Abstract
Background
Hyperglycemia-induced accumulation of reactive oxygen species (ROS) is a major risk factor for diabetic retinopathy (DR). Sarsasapogenin is a natural steroidal saponin that is known to have excellent antidiabetic effects and improve diabetic complications, but its potential efficacy and mechanism for DR are unknown.
Objectives
The current study was designed to explore whether sarsasapogenin inhibits hyperglycemia-induced oxidative stress in human retinal pigment epithelial (RPE) ARPE-19 cells and to elucidate the molecular mechanisms.
Methods
To mimic hyperglycemic conditions, ARPE-19 cells were cultured in medium containing high glucose (HG). The suppressive effects of sarsasapogenin on HG-induced cell viability reduction, apoptosis and ROS production were investigated. In addition, the relevance of the nuclear factor-kappa B (NF-κB)/NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome signaling pathway was explored to investigate the mechanism of antioxidant and anti-inflammatory activity of sarsasapogenin.
Results
Sarsasapogenin significantly alleviated cytotoxicity and apoptosis in HG-treated ARPE-19 cells through inhibition of intracellular ROS generation. Sarsasapogenin also effectively attenuated HG-induced excess accumulation of mitochondrial superoxide, reduction of glutathione content, and inactivation of manganese superoxide dismutase and glutathione peroxidase. The HG condition markedly increased the expression and maturation of interleukin (IL)-1β and IL-18 through the activation of the NF-kB signaling pathway, whereas sarsasapogenin reversed these effects. Moreover, although the expression of NLRP3 inflammasome multiprotein complex molecules was increased in ARPE-19 cells cultured under HG conditions, their levels remained similar to the control group in the presence of sarsasapogenin.
Conclusion
Sarsasapogenin could protect RPE cells from HG-induced injury by inhibiting ROS generation and NF-κB/NLRP3 inflammasome pathway, suggesting its potential as a therapeutic agent to improve the symptoms of DR.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al Mamun A, Mimi AA, Zaeem M, Wu Y, Monalisa I, Akter A, Munir F, Xiao J (2021) Role of pyroptosis in diabetic retinopathy and its therapeutic implications. Eur J Pharmacol 904:174166. https://doi.org/10.1016/j.ejphar.2021.174166
Chen H, Zhang X, Liao N, Mi L, Peng Y, Liu B, Zhang S, Wen F (2018) Enhanced expression of NLRP3 inflammasome-related inflammation in diabetic retinopathy. Invest Ophthalmol Vis Sci 59:978–985. https://doi.org/10.1167/iovs.17-22816
Cheng Y, Ren T, Wang N (2023) Biomechanical homeostasis in ocular diseases: a mini-review. Front Public Health 11:1106728. https://doi.org/10.3389/fpubh.2023.1106728
Chiang YF, Chen HY, Chang YJ, Shih YH, Shieh TM, Wang KL, Hsia SM (2020) Protective effects of fucoxanthin on high glucose- and 4-hydroxynonenal (4-HNE)-induced injury in human retinal pigment epithelial cells. Antioxid (Basel) 9:1176. https://doi.org/10.3390/antiox9121176
Choi YH (2022) Tacrolimus induces apoptosis in leukemia jurkat cells through inactivation of the reactive oxygen species-dependent phosphoinositide-3-kinase/Akt signaling pathway. Biotechnol Bioprocess Eng 27:183–192. https://doi.org/10.1007/s12257-021-0199-6
Daldal H, Nazıroğlu M (2022) Carvacrol protects the ARPE19 retinal pigment epithelial cells against high glucose-induced oxidative stress, apoptosis, and inflammation by suppressing the TRPM2 channel signaling pathways. Graefes Arch Clin Exp Ophthalmol 260:2567–2583. https://doi.org/10.1007/s00417-022-05731-5
Dammak A, Huete-Toral F, Carpena-Torres C, Martin-Gil A, Pastrana C, Carracedo G (2021) From oxidative stress to inflammation in the posterior ocular diseases: diagnosis and treatment. Pharmaceutics 13:1376. https://doi.org/10.3390/pharmaceutics13091376
di Vito R, Levorato S, Fatigoni C, Acito M, Sancineto L, Traina G, Villarini M, Santi C, Moretti M (2023) In vitro toxicological assessment of PhSeZnCl in human liver cells. Toxicol Res 39:105–114. https://doi.org/10.1007/s43188-022-00148-y
Duez H, Pourcet B (2021) Nuclear receptors in the control of the NLRP3 inflammasome pathway. Front Endocrinol (Lausanne) 12:630536. https://doi.org/10.3389/fendo.2021.630536
Gan J, Huang M, Lan G, Liu L, Xu F (2020) High glucose induces the loss of retinal pericytes partly via NLRP3-caspase-1-GSDMD-mediated pyroptosis. Biomed Res Int 2020:4510628. https://doi.org/10.1155/2020/4510628
Handy DE, Loscalzo J (2022) The role of glutathione peroxidase-1 in health and disease. Free Radic Biol Med 188:146–161. https://doi.org/10.1016/j.freeradbiomed.2022.06.004
Hong SH, Park C, Hwangbo B, Bang EJ, Kim SO, Shim JH, Park SH, Lee H, Leem SH, Kim GY, Choi YH (2022) Activation of heme oxygenase-1 is involved in the preventive effect of honokiol against oxidative damage in human retinal pigment epithelial cells. Biotechnol Bioprocess Eng 27:975–986. https://doi.org/10.1007/s12257-022-0174-x
Huo J, Meng G, Jiang X (2022) Influence of heme oxygenase-1 on rats with diabetic retinopathy through ERK1/2 signaling pathway. Cell Mol Biol (Noisy-le-grand) 68:92–97. https://doi.org/10.14715/cmb/2022.68.6.15
Hwangbo H, Kim MY, Ji SY, Kim SY, Lee H, Kim GY, Park C, Keum YS, Hong SH, Cheong J, Choi YH (2020) Auranofin attenuates non-alcoholic fatty liver disease by suppressing lipid accumulation and NLRP3 inflammasome-mediated hepatic inflammation in vivo and in vitro. Antioxid (Basel) 9:1040. https://doi.org/10.3390/antiox9111040
Indo HP, Hawkins CL, Nakanishi I, Matsumoto KI, Matsui H, Suenaga S, Davies MJ, St Clair DK, Ozawa T, Majima HJ (2017) Role of mitochondrial reactive oxygen species in the activation of cellular signals, molecules, and function. Handb Exp Pharmacol 240:439–456. https://doi.org/10.1007/164-2016-117
Kashyap P, Muthusamy K, Niranjan M, Trikha S, Kumar S (2020) Sarsasapogenin: a steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer’s disease. Steroids 153:108529. https://doi.org/10.1016/j.steroids.2019.108529
Kim MY, Bang E, Hwangbo H, Ji SY, Kim DH, Lee H, Park C, Hong SH, Kim GY, Choi YH (2023) Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3/4-dependent mitochondrial oxidative stress in RAW 264.7 and bone marrow-derived macrophages. Phytomedicine 112:154705. https://doi.org/10.1016/j.phymed.2023.154705
Kong L, Liu Y, Zhang YM, Li Y, Gou LS, Ma TF, Liu YW (2021) Sarsasapogenin ameliorates diabetes-associated memory impairment and neuroinflammation through down-regulation of PAR-1 receptor. Phytother Res 35:3167–3180. https://doi.org/10.1002/ptr.7005
Kuo CY, Maran JJ, Jamieson EG, Rupenthal ID, Murphy R, Mugisho OO (2022) Characterization of NLRP3 inflammasome activation in the onset of diabetic retinopathy. Int J Mol Sci 23:14471. https://doi.org/10.3390/ijms232214471
Li M, Tian M, Jiang X, Liu Y, Wang Y, Li Y (2022) Inhibition of galectin-3 ameliorates high-glucose-induced oxidative stress and inflammation in ARPE-19 cells. Cutan Ocul Toxicol 41:179–186. https://doi.org/10.1080/15569527.2022.2081701
Lim SM, Jeong JJ, Kang GD, Kim KA, Choi HS, Kim DH (2015) Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance. Int Immunopharmacol 25:493–503. https://doi.org/10.1016/j.intimp.2015.02.016
Lim RR, Wieser ME, Ganga RR, Barathi VA, Lakshminarayanan R, Mohan RR, Hainsworth DP, Chaurasia SS (2020) NOD-like receptors in the eye: uncovering its role in diabetic retinopathy. Int J Mol Sci 21:899. https://doi.org/10.3390/ijms21030899
Liu YW, Hao YC, Chen YJ, Yin SY, Zhang MY, Kong L, Wang TY (2018) Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats. Phytother Res 32:1574–1582. https://doi.org/10.1002/ptr.6088
Liu M, Sun X, Chen B, Dai R, Xi Z, Xu H (2022b) Insights into manganese superoxide dismutase and human diseases. Int J Mol Sci 23:15893. https://doi.org/10.3390/ijms232415893
Mandell JT, de Rivero Vaccari JP, Sabater AL, Galor A (2023) The inflammasome pathway: a key player in ocular surface and anterior segment diseases. Surv Ophthalmol 68:280–289. https://doi.org/10.1016/j.survophthal.2022.06.003
Mandlik DS, Mandlik SK, Patel S (2021) Protective effect of sarsasapogenin in TNBS induced ulcerative colitis in rats associated with downregulation of pro-inflammatory mediators and oxidative stress. Immunopharmacol Immunotoxicol 43:571–583. https://doi.org/10.1080/08923973.2021.1955919
Marahatha R, Gyawali K, Sharma K, Gyawali N, Tandan P, Adhikari A, Timilsina G, Bhattarai S, Lamichhane G, Acharya A, Pathak I, Devkota HP, Parajuli N (2021) Pharmacologic activities of phytosteroids in inflammatory diseases: mechanism of action and therapeutic potentials. Phytother Res 35:5103–5124. https://doi.org/10.1002/ptr.7138
Mu L, Wang D, Dong Z, Wu J, Wu X, Su J, Zhang Y (2022) Abnormal levels of serum ferroptosis-related biomarkers in diabetic retinopathy. J Ophthalmol 2022:3353740. https://doi.org/10.1155/2022/3353740
Mukherjee S, Choi M, Yun JW (2022) Trans-anethole induces thermogenesis via activating SERCA/SLN axis in C2C12 muscle cells. Biotechnol Bioprocess Eng 27:938–948. https://doi.org/10.1007/s12257-022-0242-2
Mustafa NH, Sekar M, Fuloria S, Begum MY, Gan SH, Rani NNIM, Ravi S, Chidambaram K, Subramaniyan V, Sathasivam KV, Jeyabalan S, Uthirapathy S, Ponnusankar S, Lum PT, Bhalla V, Fuloria NK (2022) Chemistry, biosynthesis and pharmacology of sarsasapogenin: a potential natural steroid molecule for new drug design, development and therapy. Molecules 27:2032. https://doi.org/10.3390/molecules27062032
O’Brien M, Moehring D, Muñoz-Planillo R, Núñez G, Callaway J, Ting J, Scurria M, Ugo T, Bernad L, Cali J, Lazar D (2017) A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. J Immunol Methods 447:1–13. https://doi.org/10.1016/j.jim.2017.03.004
Paerewijck O, Lamkanfi M (2022) The human inflammasomes. Mol Aspects Med 88:101100. https://doi.org/10.1016/j.mam.2022.101100
Park J, Heo YJ, Kwon S (2022a) Interaction between hepatocytes and proximal tubular epithelial cells in hypoxia-induced lipotoxicity. Biotechnol Bioprocess Eng 27:30–39. https://doi.org/10.1007/s12257-021-0137-7
Park C, Lee H, Kim SO, Lee EW, Lee HT, Kwon HJ, Kim BW, Kim GY, Kim MR, Choi YH (2022b) The preventive effect of Mori Ramulus on oxidative stress-induced cellular damage in skeletal L6 myoblasts through Nrf2-mediated activation of HO-1. Toxicol Res 39:25–36. https://doi.org/10.1007/s43188-022-00141-5
Pei J, Pan X, Wei G, Hua Y (2023) Research progress of glutathione peroxidase family (GPX) in redoxidation. Front Pharmacol 14:1147414. https://doi.org/10.3389/fphar.2023.1147414
Rieger AM, Nelson KL, Konowalchuk JD, Barreda DR (2011) Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp 24:2597. https://doi.org/10.3791/2597
Sharma I, Yadav KS, Mugale MN (2022) Redoxisome and diabetic retinopathy: pathophysiology and therapeutic interventions. Pharmacol Res 182:106292. https://doi.org/10.1016/j.phrs.2022.106292
Singh LP, Devi TS, Yumnamcha T (2017) The role of Txnip in mitophagy dysregulation and inflammasome activation in diabetic retinopathy: a new perspective. JOJ Ophthalmol 4. https://doi.org/10.19080/jojo.2017.04.555643
Tang ZZ, Zhang YM, Zheng T, Huang TT, Ma TF, Liu YW (2020) Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: in vivo and in vitro study. Phytomedicine 78:153314. https://doi.org/10.1016/j.phymed.2020.153314
Tang X, Li X, Zhang D, Han W (2022) Astragaloside-IV alleviates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2. Bioengineered 13:8240–8254. https://doi.org/10.1080/21655979.2022.2049471
Wang J, Li M, Geng Z, Khattak S, Ji X, Wu D, Dang Y (2022) Role of oxidative stress in retinal disease and the early intervention strategies: A review. Oxid Med Cell Longev 2022: 7836828. doi: https://doi.org/10.1155/2022/7836828
Wu MY, Yiang GT, Lai TT, Li CJ (2018) The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxid Med Cell Longev 2018:3420187. https://doi.org/10.1155/2018/3420187
Xiaodong L, Xuejun X (2023) GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review. Int Ophthalmol 43:1405–1411. https://doi.org/10.1007/s10792-022-02506-z
Yang X, Li D (2023) Tricin attenuates diabetic retinopathy by inhibiting oxidative stress and angiogenesis through regulating Sestrin2/Nrf2 signaling. Hum Exp Toxicol 42:9603271231171642. https://doi.org/10.1177/09603271231171642
Yang Y, Jiang G, Huang R, Liu Y, Chang X, Fu S (2023) Targeting the NLRP3 inflammasome in diabetic retinopathy: from pathogenesis to therapeutic strategies. Biochem Pharmacol 212:115569. https://doi.org/10.1016/j.bcp.2023.115569
Yoshinaga A, Kajihara N, Kukidome D, Motoshima H, Matsumura T, Nishikawa T, Araki E (2021) Hypoglycemia induces mitochondrial reactive oxygen species production through increased fatty acid oxidation and promotes retinal vascular permeability in diabetic mice. Antioxid Redox Signal 34:1245–1259. https://doi.org/10.1089/ars.2019.8008
Yumnamcha T, Devi TS, Singh LP (2019) Auranofin mediates mitochondrial dysregulation and inflammatory cell death in human retinal pigment epithelial cells: implications of retinal neurodegenerative diseases. Front Neurosci 13:1065. https://doi.org/10.3389/fnins.2019.01065
Zhan D, Zhao J, Shi Q, Lou J, Wang W (2023) 25-Hydroxyvitamin D3 inhibits oxidative stress and ferroptosis in retinal microvascular endothelial cells induced by high glucose through down-regulation of miR-93. BMC Ophthalmol 23:22. https://doi.org/10.1186/s12886-022-02762-8
Zhang Y, Jiao Y, Li X, Gao S, Zhou N, Duan J, Zhang M (2021) Pyroptosis: a new insight into eye disease therapy. Front Pharmacol 12:797110. https://doi.org/10.3389/fphar.2021.797110
Zheng X, Wan J, Tan G (2023) The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy. Front Immunol 14:1151185. https://doi.org/10.3389/fimmu.2023.1151185
Zhou Z, Xu S, Jiang L, Tan Z, Wang J (2022) A systematic pan-cancer analysis of CASP3 as a potential target for immunotherapy. Front Mol Biosci 9:776808. https://doi.org/10.3389/fmolb.2022.776808
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
I declare that I have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Choi, Y.H. Reduction of high glucose-induced oxidative injury in human retinal pigment epithelial cells by sarsasapogenin through inhibition of ROS generation and inactivation of NF-κB/NLRP3 inflammasome pathway. Genes Genom 45, 1153–1163 (2023). https://doi.org/10.1007/s13258-023-01417-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-023-01417-2